ロード中...
Tardive dyskinesia in 2 patients treated with ziprasidone
Ziprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including tardive dyskinesia (TD). Two of our patients developed TD after 23 months and 34 months of ziprasidone monotherapy, respectively. One of the patients had had earlie...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC524964/ https://ncbi.nlm.nih.gov/pubmed/15644988 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|